XWEL
XWELL Inc.
NASDAQ: XWEL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$1.18
+2.61% today
Updated 2026-04-30
Market cap
$9.43M
P/E ratio
—
P/S ratio
0.32x
EPS (TTM)
$-5.08
Dividend yield
—
52W range
$0 – $2
Volume
10.0M
XWELL Inc. (XWEL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-58.20%
Operating margin
-45.10%
ROE
-159.00%
ROA
-32.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-7.33M | — | — | — |
| 2009 | $20000.00 | $-6.15M | -55.00% | -26,530.00% | -30,745.00% |
| 2010 | $211000.00 | $-9.94M | 14.69% | -3,078.20% | -4,711.85% |
| 2011 | $718000.00 | $-7.48M | 78.41% | -894.71% | -1,041.64% |
| 2012 | $369000.00 | $-20.84M | -3,290.79% | -6,712.20% | -5,647.97% |
| 2013 | $1.10M | $-52.43M | -1,862.73% | -3,707.00% | -4,766.64% |
| 2014 | $1.43M | $-109.68M | -1,680.21% | -7,803.23% | -7,696.63% |
| 2015 | $22.69M | $-11.16M | 14.70% | -45.59% | -49.18% |
| 2016 | $18.97M | $-24.01M | 32.44% | -118.15% | -126.52% |
| 2017 | $48.82M | $-28.84M | 19.42% | -30.87% | -59.07% |
| 2018 | $50.09M | $-37.20M | 21.25% | -69.32% | -74.27% |
| 2019 | $48.52M | $-21.22M | 21.97% | -32.72% | -43.75% |
| 2020 | $8.38M | $-90.49M | -42.91% | -478.28% | -1,079.17% |
| 2021 | $73.73M | $3.35M | 43.87% | 5.57% | 4.54% |
| 2022 | $55.94M | $-32.84M | 21.54% | -55.71% | -58.70% |
| 2023 | $30.11M | $-27.74M | 12.23% | -93.68% | -92.14% |
| 2024 | $33.90M | $-16.85M | 26.31% | -49.29% | -49.72% |
| 2025 | $29.21M | $-16.99M | 22.75% | -32.03% | -58.17% |